These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


54 related items for PubMed ID: 989388

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In vivo receptor binding of opioid drugs at the mu site.
    Rosenbaum JS, Holford NH, Sadée W.
    J Pharmacol Exp Ther; 1985 Jun; 233(3):735-40. PubMed ID: 2989495
    [Abstract] [Full Text] [Related]

  • 5. Irreversible opiate agonists and antagonists. II. Evidence against a bivalent mechanism of action for opiate azines and diacylhydrazones.
    Hahn EF, Nishimura S, Goodman RR, Pasternak GW.
    J Pharmacol Exp Ther; 1985 Dec; 235(3):839-45. PubMed ID: 2416909
    [Abstract] [Full Text] [Related]

  • 6. Etorphine binds to multiple opiate receptors of the caudate nucleus with equal affinity but with different kinetics.
    Tolkovsky AM.
    Mol Pharmacol; 1982 Nov; 22(3):648-56. PubMed ID: 6296657
    [Abstract] [Full Text] [Related]

  • 7. Naloxazone, a long-acting opiate antagonist: effects on analgesia in intact animals and on opiate receptor binding in vitro.
    Pasternak GW, Childers SR, Snyder SH.
    J Pharmacol Exp Ther; 1980 Sep; 214(3):455-62. PubMed ID: 6105201
    [Abstract] [Full Text] [Related]

  • 8. Opioid agonist and antagonist treatment differentially regulates immunoreactive mu-opioid receptors and dynamin-2 in vivo.
    Yoburn BC, Purohit V, Patel K, Zhang Q.
    Eur J Pharmacol; 2004 Sep 13; 498(1-3):87-96. PubMed ID: 15363980
    [Abstract] [Full Text] [Related]

  • 9. Stereoisomers of [3H]-N-allylnormetazocine bind to different sites in mouse brain.
    Martin BR, Katzen JS, Woods JA, Tripathi HL, Harris LS, May EL.
    J Pharmacol Exp Ther; 1984 Dec 13; 231(3):539-44. PubMed ID: 6094791
    [Abstract] [Full Text] [Related]

  • 10. Characterization of specific opioid binding sites in neural membranes from the myenteric plexus of porcine small intestine.
    Townsend D, Portoghese PS, Brown DR.
    J Pharmacol Exp Ther; 2004 Jan 13; 308(1):385-93. PubMed ID: 14569065
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Discrimination of three types of opioid binding sites in rat brain in vivo.
    Rosenbaum JS, Holford NH, Richards ML, Aman RA, Sadée W.
    Mol Pharmacol; 1984 Mar 13; 25(2):242-8. PubMed ID: 6321946
    [Abstract] [Full Text] [Related]

  • 14. Further properties of stereospecific opiate binding sites in rat brain: on the nature of the sodium effect.
    Simon EJ, Hiller JM, Groth J, Edelman I.
    J Pharmacol Exp Ther; 1975 Mar 13; 192(3):531-7. PubMed ID: 235639
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Buprenorphine: differential interaction with opiate receptor subtypes in vivo.
    Sadée W, Rosenbaum JS, Herz A.
    J Pharmacol Exp Ther; 1982 Oct 13; 223(1):157-62. PubMed ID: 6288917
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 3.